Is Gelatin Still Irreplaceable? What Industry Data Says About Plant-Based Alternatives
The debate has been going on for years. As plant-based trends reshape food and pharmaceutical manufacturing, one question keeps surfacing in procurement meetings and R&D labs alike: can gelatin be replaced? The answer, backed by fresh global data, is more nuanced - and more favourable to gelatin - than many expect.
What the Numbers Actually Show About Gelatin Industry
In 2024, GROW - the global coalition of gelatin industry associations representing Europe, North America, South America, and Asia-Pacific - published results of a large-scale international survey [1]. Researchers interviewed 600 industry professionals across six countries: the United States, Brazil, France, Germany, Japan, and South Korea. Respondents came from dairy, confectionery, health and nutrition, pharmaceutical, and technical application sectors.
One finding stands out immediately. Across the US, Germany, France, and South Korea, the share of manufacturers currently working with gelatin alternatives is lower than the share who tried those alternatives in the past [1]. In Germany, the gap is the most pronounced: 36% of respondents had previously experimented with substitutes, but only 24% continue to do so today. France shows a similar pattern - 44% tried alternatives, 33% still use them [1].
The data suggests that in several major markets and high-performance sectors, many manufacturers test alternatives but continue to rely on gelatin where functional requirements remain demanding.
Why Alternatives Struggle to Compete With Gelatin
The plant-based hydrocolloids most commonly considered as gelatin substitutes - agar, pectin, and carrageenan - each carry specific functional limitations that become apparent at the production scale.
Agar sets firmly and tolerates high temperatures well, which sounds like an advantage. In practice, agar gels are brittle and lack the elasticity that confectionery and pharmaceutical applications require [2]. More critically, agar melts only above 85°C - far above body temperature. Standard fast-dissolving pharmaceutical capsules require shell materials that disintegrate rapidly under gastric conditions; agar's thermal properties make it poorly suited for this role.
Pectin performs well in fruit-based confectionery and jam production. However, it cannot replicate gelatin's thermo-reversible behaviour - the ability to melt and re-set repeatedly without losing structural integrity [3]. Pectin also requires specific pH and sugar concentration conditions to gel effectively, narrowing its application window considerably.
Carrageenan has been the subject of ongoing scientific debate regarding the behaviour of its degraded forms, and EFSA's 2018 re-evaluation recommended further data to confirm acceptable daily intake levels [8]. For manufacturers targeting clean-label positioning, this uncertainty can complicate ingredient sourcing decisions.
None of these alternatives deliver what food scientists describe as gelatin's most distinctive functional attribute: the melt-in-mouth effect. Because gelatin gels melt at temperatures between 25°C and 32°C - just below body temperature - they dissolve on contact with the palate, releasing flavour and aroma in a way no plant-based hydrocolloid currently replicates [4]. As researchers have noted, scientists have not yet identified a gelling protein or polysaccharide that universally reproduces this property [4].
The Pharmaceutical Gap Is Even Wider
In pharmaceutical manufacturing, the case for gelatin becomes stronger still. Hard and soft capsules made from gelatin remain the global standard for oral drug delivery, and for reasons that go beyond convention.
Pharmaceutical-grade gelatin must comply with the European Pharmacopoeia (Ph. Eur.) and the United States Pharmacopeia (USP) - the two primary reference standards for medicinal excipients [5]. These frameworks regulate bloom strength consistency, viscosity, microbial limits, heavy metal content, and dissolution profiles. Plant-based alternatives may meet selected requirements, but the available evidence does not demonstrate an equivalent track record to gelatin across pharmaceutical capsule performance, processing behaviour, and regulatory familiarity [5].
From a manufacturing standpoint, gelatin's thermo-reversible gelling behaviour - melting and setting reversibly at defined temperatures - allows encapsulation lines to operate with precision and speed [5]. The triple helix protein structure that forms upon cooling is the foundation of capsule shell integrity: it determines wall strength, seal quality, and resistance to mechanical stress during packaging and transport [5]. Critically, a gelatin capsule dissolves within 10 to 20 minutes in gastric conditions, enabling predictable and fast release of active pharmaceutical ingredients [5]. Plant-based capsule alternatives, such as hydroxypropyl methylcellulose (HPMC), can show slower disintegration profiles in certain formulations - a variable that must be evaluated and addressed during product development [5].
For manufacturers supplying the global pharmaceutical gelatin market, these are not abstract distinctions. They translate directly into batch consistency, regulatory approval timelines, and clinical efficacy.
What Manufacturers Actually Value in Gelatin
The GROW survey asked participants to identify the most important factors driving their preference for gelatin [1]. The top three responses were:
- Product performance - cited by 40% of respondents
- Low cost of use - cited by over one third
- Reliability - cited by 32%
These are procurement-level priorities. Not marketing language - functional and economic criteria that govern sourcing decisions at scale.
When asked about gelatin's most relevant technical properties, respondents pointed to ease of use (nearly 50%), texture contribution (38%), and gel-forming capability (35%) [1]. For manufacturers working in gelatin-based delivery formats, the thermo-reversible property scored notably higher than the overall average - 24% versus 12% across all sectors [1].
The picture that emerges is of an ingredient chosen not out of habit, but because it consistently delivers what many alternatives have not consistently replicated.
Sustainability: A Misunderstood Advantage of Gelatin
The plant-based narrative often frames sustainability as an argument against gelatin. The data suggests the opposite perception is taking hold among industrial buyers.
In the GROW survey, 87% of respondents stated that integrating upcycled products into the value chain is important for their company [1]. At the same time, 71% of participants identified gelatin itself as an upcycled product - derived from by-products of meat processing that would otherwise require disposal [1].
This matters for clean-label strategy. In the EU, gelatin is classified as a foodstuff - not a food additive - and therefore requires no E number on product labels [6]. In the US, it has received Generally Recognised As Safe (GRAS) status from the FDA [7]. In an era when 88% of surveyed manufacturers say using natural, minimally processed ingredients is important to their operations [1], gelatin's profile as a natural, upcycled protein aligns well with procurement direction of travel.
The Plant-Based Trend Is Real - But Selective
None of this dismisses the plant-based trend. In the GROW survey, 25% of respondents identified the growing preference for plant-based alternatives as an emerging market force [1]. That is a significant signal, and manufacturers of edible gelatin are right to monitor it closely.
But the same survey reveals that this trend is sector-specific. In desserts and technical applications, plant-based substitutes are gaining ground [1]. In dairy and health & nutrition - two of the largest segments for industrial gelatin - the pattern reverses: 36% and 38% of respondents in those sectors, respectively, have tried alternatives but returned to gelatin [1].
In some of the sectors where alternatives are advancing, the required functional profile may differ from applications where elasticity, rapid dissolution, or melt-in-mouth behaviour are critical. Where texture precision, flavour release, dissolution behaviour, or pharmaceutical compliance are at stake, the substitution case weakens substantially.
What This Means for Sourcing Decisions
For procurement managers and R&D technologists evaluating their ingredient strategy, the survey data points in a clear direction: gelatin's position remains strong in many high-performance applications, not because of market inertia, but because of functional properties that alternatives have not yet replicated.
For manufacturers seeking a reliable European source of both edible and pharmaceutical-grade gelatin - produced under ISO 9001, ISO 22000, and BRCGS Food Safety Grade AA certification - Brodnica Gelatin has supplied industrial customers across 19 countries for over 88 years.
Contact our team to discuss product specifications, bloom strength requirements, or sample requests.
Bibliography
[1] GROW - Gelatin Representatives of the World. Global Gelatin Survey 2024. https://www.gelatininfo.com/global-gelatin-survey.html
[2] Saha, D., Bhattacharya, S. Hydrocolloids as thickening and gelling agents in food: a critical review. Journal of Food Science and Technology, 47(6), 587–597 (2010). https://link.springer.com/article/10.1007/s13197-010-0162-6
[3] Pacific Pectin Inc. Pectin vs Gelatin: Complete Comparison Guide. https://pacificpectin.com/difference-between-pectin-and-gelatin/
[4] Prepared Foods. Gelatin and its Hydrocolloid Alternatives (January 2011). https://www.preparedfoods.com/articles/109487-article-gelatin-and-its-hydrocolloid-alternatives-january-2011
[5] PMC / National Library of Medicine. Challenges of Dissolution Methods Development for Soft Gelatin Capsules. https://pmc.ncbi.nlm.nih.gov/articles/PMC7913951/
[6] Gelatine Manufacturers of Europe (GME). Properties & Advantages of Gelatine. https://www.gelatine.org/en/gelatine/properties-advantages.html
[7] U.S. Food and Drug Administration. GRAS Substances (SCOGS) Database - Gelatin. https://www.fda.gov/food/generally-recognized-safe-gras/gras-substances-scogs-database
[8] European Food Safety Authority (EFSA). Re-evaluation of carrageenan (E 407) and processed Eucheuma seaweed (E 407a) as food additives (2018). https://pmc.ncbi.nlm.nih.gov/articles/PMC7009739/
